Advanced Search
Share
Current Issue
Journal Information
Back to article

Statistics

Follow this link to access the full text of the article

228
USO DE UM SEGUNDO INIBIDOR DE TIROSINA QUINASE DE SEGUNDA GERAÇÃO COMO TERAPIA DE TERCEIRA LINHA EM PACIENTES COM LMC FASE CRÔNICA
A.B.V.D. Santos, F.A.M. Oliveira, T.C. Bortolheiro
Irmandade da Santa Casa de Misericórdia de São Paulo, São Paulo, SP, Brasil
Read
2003
Times
was read the article
931
Total PDF
1072
Total HTML
Share statistics
Article information
ISSN: 25311379
Original language: English
DOI:10.1016/j.htct.2020.10.229
The statistics are updated each day
Year/Month Html Pdf Total
2024 April 39 18 57
2024 March 42 18 60
2024 February 28 18 46
2024 January 24 19 43
2023 December 21 17 38
2023 November 38 22 60
2023 October 23 22 45
2023 September 27 32 59
2023 August 13 16 29
2023 July 30 15 45
2023 June 25 16 41
2023 May 25 13 38
2023 April 24 7 31
2023 March 13 14 27
2023 February 15 17 32
2023 January 20 3 23
2022 December 22 18 40
2022 November 17 28 45
2022 October 22 20 42
2022 September 18 30 48
2022 August 24 18 42
2022 July 19 30 49
2022 June 30 18 48
2022 May 13 22 35
2022 April 22 29 51
2022 March 23 22 45
2022 February 19 16 35
2022 January 15 22 37
2021 December 14 17 31
2021 November 36 29 65
2021 October 41 37 78
2021 September 35 30 65
2021 August 32 26 58
2021 July 40 38 78
2021 June 31 28 59
2021 May 22 35 57
2021 April 47 49 96
2021 March 41 28 69
2021 February 20 18 38
2021 January 16 22 38
2020 December 20 20 40
2020 November 26 14 40
Show all

Follow this link to access the full text of the article

Subscribe to our newsletter

Special content about COVID-19
Publish in
Hematology, Transfusion and Cell Therapy
Hematology, Transfusion and Cell Therapy is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.
Idiomas
Hematology, Transfusion and Cell Therapy